Antibodies

DBCAT000016Pharmacologic class

Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA... A DrugBank category of 543 drugs. 187 of them are approved.

Drugs: Abagovomab
Abatacept
Abciximab
Abelacimab
Abituzumab
Abrilumab
Acimtamig
Actoxumab
Adakitug
Adalimumab
Adecatumumab
Aducanumab
Afelimomab
AGS-16C3F
Alefacept
Alemtuzumab
Alirocumab
Amatuximab
AMG 108
Amivantamab
Amubarvimab
Andecaliximab
Anetumab ravtansine
Anifrolumab
Anrukinzumab
and 518 more with a free account

What you can answer from here — as of August 24, 2016

543DrugsEach linked to its full drug card

286Drug targetsEvery drug–target pair in the class, with bond type

5,874Marketed productsAcross the regions we cover, with dosage forms and routes

16Routes of administrationHow the drugs in this class are given

3SubcategoriesNarrower classes within this one

Which targets do Antibodies share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account